{"id":"https://openalex.org/W4294074009","doi":"https://doi.org/10.1080/14786419.2022.2117174","title":"Synthesis, molecular docking and anti-inflammatory evaluation of new trisubstituted pyrazoline derivatives bearing benzenesulfonamide moiety","display_name":"Synthesis, molecular docking and anti-inflammatory evaluation of new trisubstituted pyrazoline derivatives bearing benzenesulfonamide moiety","publication_year":2022,"publication_date":"2022-09-01","ids":{"openalex":"https://openalex.org/W4294074009","doi":"https://doi.org/10.1080/14786419.2022.2117174","pmid":"https://pubmed.ncbi.nlm.nih.gov/36047992"},"language":"en","primary_location":{"id":"doi:10.1080/14786419.2022.2117174","doi":"https://doi.org/10.1080/14786419.2022.2117174","is_oa":false,"landing_page_url":"https://doi.org/10.1080/14786419.2022.2117174","pdf_url":null,"source":{"id":"https://openalex.org/S205999849","display_name":"Natural Product Research","issn_l":"1478-6419","issn":["1478-6419","1478-6427"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Natural Product Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/journal_contribution/Synthesis_molecular_docking_and_anti-inflammatory_evaluation_of_new_trisubstituted_pyrazoline_derivatives_bearing_benzenesulfonamide_moiety/20768784","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000579801","display_name":"Ayad M.R. Raauf","orcid":"https://orcid.org/0000-0002-8957-2093","observed_orcids":["https://orcid.org/0000-0002-8957-2093"]},"institutions":[{"id":"https://openalex.org/I15873915","display_name":"Mustansiriyah University","ror":"https://ror.org/05s04wy35","country_code":"IQ","type":"education","lineage":["https://openalex.org/I15873915"]}],"countries":["IQ"],"is_corresponding":true,"raw_author_name":"Ayad M. R. Raauf","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq"],"raw_orcid":"https://orcid.org/0000-0002-8957-2093","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq","institution_ids":["https://openalex.org/I15873915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015486526","display_name":"Tagreed N-A Omar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I135120706","display_name":"University of Baghdad","ror":"https://ror.org/007f1da21","country_code":"IQ","type":"education","lineage":["https://openalex.org/I135120706"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Tagreed N-A Omar","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, College of Pharmacy, University of Baghdad, Baghdad, Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, College of Pharmacy, University of Baghdad, Baghdad, Iraq","institution_ids":["https://openalex.org/I135120706"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078706267","display_name":"Monther Faisal Mahdi","orcid":"https://orcid.org/0000-0002-2069-4121","observed_orcids":["https://orcid.org/0000-0002-2069-4121"]},"institutions":[{"id":"https://openalex.org/I15873915","display_name":"Mustansiriyah University","ror":"https://ror.org/05s04wy35","country_code":"IQ","type":"education","lineage":["https://openalex.org/I15873915"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Monther F. Mahdi","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq","institution_ids":["https://openalex.org/I15873915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091042367","display_name":"Hayder R. Fadhil","orcid":"https://orcid.org/0000-0002-6500-2846","observed_orcids":["https://orcid.org/0000-0002-6500-2846"]},"institutions":[{"id":"https://openalex.org/I15873915","display_name":"Mustansiriyah University","ror":"https://ror.org/05s04wy35","country_code":"IQ","type":"education","lineage":["https://openalex.org/I15873915"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Hayder R. Fadhil","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq","institution_ids":["https://openalex.org/I15873915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5000579801"],"corresponding_institution_ids":["https://openalex.org/I15873915"],"apc_list":null,"apc_paid":null,"fwci":1.7636,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.84205936,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"38","issue":"2","first_page":"253","last_page":"260"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13023","display_name":"Synthesis of Organic Compounds","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benzenesulfonamide-derivatives","display_name":"benzenesulfonamide derivatives","score":0.9200000166893005},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.8379999995231628},{"id":"https://openalex.org/keywords/cox-2-inhibition","display_name":"COX-2 inhibition","score":0.9369999766349792},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.9100000262260437},{"id":"https://openalex.org/keywords/celecoxib-comparison","display_name":"celecoxib comparison","score":0.7070000171661377}],"concepts":[{"id":"https://openalex.org/C2776568683","wikidata":"https://www.wikidata.org/wiki/Q23005640","display_name":"Moiety","level":2,"score":0.8719233274459839},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7986341714859009},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.7955623865127563},{"id":"https://openalex.org/C2776467144","wikidata":"https://www.wikidata.org/wiki/Q408801","display_name":"Celecoxib","level":2,"score":0.638361394405365},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5775867700576782},{"id":"https://openalex.org/C2779703632","wikidata":"https://www.wikidata.org/wiki/Q581996","display_name":"Anti-inflammatory","level":2,"score":0.5610584020614624},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.553509533405304},{"id":"https://openalex.org/C2780744904","wikidata":"https://www.wikidata.org/wiki/Q7263415","display_name":"Pyrazoline","level":2,"score":0.4801335036754608},{"id":"https://openalex.org/C41183919","wikidata":"https://www.wikidata.org/wiki/Q423026","display_name":"Active site","level":3,"score":0.4626947343349457},{"id":"https://openalex.org/C2779485729","wikidata":"https://www.wikidata.org/wiki/Q210385","display_name":"Pyridine","level":2,"score":0.43832963705062866},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3696269989013672},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3109309673309326},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2424229085445404},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.22630921006202698},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.19852429628372192},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.06869551539421082},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068579","descriptor_name":"Celecoxib","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000068579","descriptor_name":"Celecoxib","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000096926","descriptor_name":"Benzenesulfonamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004487","descriptor_name":"Edema","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004487","descriptor_name":"Edema","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051546","descriptor_name":"Cyclooxygenase 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D062105","descriptor_name":"Molecular Docking Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1080/14786419.2022.2117174","doi":"https://doi.org/10.1080/14786419.2022.2117174","is_oa":false,"landing_page_url":"https://doi.org/10.1080/14786419.2022.2117174","pdf_url":null,"source":{"id":"https://openalex.org/S205999849","display_name":"Natural Product Research","issn_l":"1478-6419","issn":["1478-6419","1478-6427"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Natural Product Research","raw_type":"journal-article"},{"id":"pmid:36047992","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36047992","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Natural product research","raw_type":"Journal Article"},{"id":"pmh:oai:figshare.com:article/20768784","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Synthesis_molecular_docking_and_anti-inflammatory_evaluation_of_new_trisubstituted_pyrazoline_derivatives_bearing_benzenesulfonamide_moiety/20768784","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"doi:10.6084/m9.figshare.20768784.v1","doi":"https://doi.org/10.6084/m9.figshare.20768784.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.20768784.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/20768784","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Synthesis_molecular_docking_and_anti-inflammatory_evaluation_of_new_trisubstituted_pyrazoline_derivatives_bearing_benzenesulfonamide_moiety/20768784","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"score":0.4043000042438507,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1025777542","https://openalex.org/W1976199514","https://openalex.org/W2018037575","https://openalex.org/W2050456292","https://openalex.org/W2052030759","https://openalex.org/W2054393563","https://openalex.org/W2076490881","https://openalex.org/W2087194737","https://openalex.org/W2112845321","https://openalex.org/W2179400574","https://openalex.org/W2469774890","https://openalex.org/W2769096052","https://openalex.org/W2794382363","https://openalex.org/W2800749330","https://openalex.org/W3005148357","https://openalex.org/W3177325971","https://openalex.org/W4245966879"],"related_works":["https://openalex.org/W2949701762","https://openalex.org/W2296936662","https://openalex.org/W1990636333","https://openalex.org/W4381142333","https://openalex.org/W7134193144","https://openalex.org/W3117651663","https://openalex.org/W4206379805","https://openalex.org/W4281820444","https://openalex.org/W3171980985","https://openalex.org/W4229026582"],"abstract_inverted_index":{"A":[0],"new":[1],"series":[2],"of":[3],"trisubstituted":[4],"pyrazoline":[5],"bearing":[6,52],"benzenesulfonamide":[7,58],"moiety":[8,54],"6a,b\u201310a,b":[9,46],"were":[10,47],"designed,":[11],"synthesised":[12,48],"and":[13,87,97,107],"evaluated":[14],"for":[15],"their":[16,62],"anti-inflammatory":[17,63],"in":[18],"vitro.":[19],"Before":[20],"starting":[21],"the":[22,33],"synthesis,":[23],"docking":[24,114],"study":[25],"has":[26],"been":[27],"used":[28],"to":[29,75],"insert":[30],"compounds":[31,45],"within":[32],"COX-2":[34],"structure":[35],"active":[36],"site":[37],"using":[38,67],"celecoxib":[39,105],"drug":[40,104],"as":[41],"a":[42],"reference.":[43],"Final":[44],"by":[49],"condensing":[50],"chalcones":[51],"pyridine":[53],"1a,b\u20135a,b":[55],"with":[56,101,113],"4-hydrazinyl":[57],"hydrochloride.":[59],"In":[60],"vitro,":[61],"activity":[64],"was":[65],"assessed":[66],"egg-white":[68],"paw":[69],"edema":[70],"method,":[71],"they":[72],"showed":[73],"moderate":[74],"strong":[76],"inhibitory":[77],"activity.":[78],"Notably,":[79],"Compounds":[80],"6a":[81],"(29.78%),":[82],"7a":[83],"(28.43%),":[84],"9a":[85],"(27.92%)":[86,89],"10a":[88],"exhibited":[90],"significant":[91],"percentage":[92,102],"inhibition":[93,103],"at":[94],"300":[95],"min":[96],"results":[98],"are":[99],"comparable":[100],"(22.67%)":[106],"this":[108],"result":[109],"is":[110],"highly":[111],"agreement":[112],"scoring":[115],"study.":[116]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":5}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2022-09-01T00:00:00"}